Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bacchetti

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Annals of Internal Medicine|September 11, 2003
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trialDonald I Abrams, Joan F Hilton, Roslyn J Leiser, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 19, 2015
Implementation and Operational Research: Pulling the Network Together: Quasiexperimental Trial of a Patient-Defined Support Network Intervention for Promoting Engagement in HIV Care and Medication Adherence on Mfangano Island, KenyaMatthew D Hickey, Charles R Salmen, Dan Omollo, et al.
The Journal of Infectious Diseases|March 10, 2020
Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir SizeMars Stone, Daniel I S Rosenbloom, Peter Bacchetti, et al.
Journal of Virology|November 15, 2019
Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic SitesEunok Lee, Susanne von Stockenstrom, Vincent Morcilla, et al.
Molecular Medicine (Cambridge, Mass.)|March 9, 2012
The calm mouse: an animal model of stress reductionBlake T Gurfein, Andrew W Stamm, Peter Bacchetti, et al.
AIDS Research and Human Retroviruses|March 3, 2017
Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair ConcentrationsCatherine A Koss, Peter Bacchetti, Sharon L Hillier, et al.
The Journal of Infectious Diseases|December 5, 2019
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral TherapyJenny L Anderson, Gabriela Khoury, Rémi Fromentin, et al.
Plos Computational Biology|April 13, 2019
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir sizeDaniel I S Rosenbloom, Peter Bacchetti, Mars Stone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over timeLina Josefsson, Susanne von Stockenstrom, Nuno R Faria, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Annals of Internal Medicine|September 11, 2003
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trialDonald I Abrams, Joan F Hilton, Roslyn J Leiser, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 19, 2015
Implementation and Operational Research: Pulling the Network Together: Quasiexperimental Trial of a Patient-Defined Support Network Intervention for Promoting Engagement in HIV Care and Medication Adherence on Mfangano Island, KenyaMatthew D Hickey, Charles R Salmen, Dan Omollo, et al.
The Journal of Infectious Diseases|March 10, 2020
Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir SizeMars Stone, Daniel I S Rosenbloom, Peter Bacchetti, et al.
Journal of Virology|November 15, 2019
Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic SitesEunok Lee, Susanne von Stockenstrom, Vincent Morcilla, et al.
Molecular Medicine (Cambridge, Mass.)|March 9, 2012
The calm mouse: an animal model of stress reductionBlake T Gurfein, Andrew W Stamm, Peter Bacchetti, et al.
AIDS Research and Human Retroviruses|March 3, 2017
Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair ConcentrationsCatherine A Koss, Peter Bacchetti, Sharon L Hillier, et al.
The Journal of Infectious Diseases|December 5, 2019
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral TherapyJenny L Anderson, Gabriela Khoury, Rémi Fromentin, et al.
Plos Computational Biology|April 13, 2019
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir sizeDaniel I S Rosenbloom, Peter Bacchetti, Mars Stone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over timeLina Josefsson, Susanne von Stockenstrom, Nuno R Faria, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
Pageof 25